Evidence map›Paper›PMID 26417529›Full record

ArticleBiomedical optics express2015

Pump-probe imaging of pigmented cutaneous melanoma primary lesions gives insight into metastatic potential.

Francisco E Robles, Sanghamitra Deb, Jesse W Wilson, Christina S Gainey, M Angelica Selim, Paul J Mosca, Douglas S Tyler, Martin C Fischer, Warren S Warren

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Qualitative and quantitative assessment ofBiomedical optics express · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Francisco E RoblesDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA.
Sanghamitra DebDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA.
Jesse W WilsonDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA.
Christina S GaineyDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA.
M Angelica SelimDepartment of Pathology, Duke University Medical Center, Durham, NC 27705, USA.
Paul J MoscaDepartment of Surgery, Duke University Medical Center, Durham, NC 27705, USA.
Douglas S TylerDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.
Martin C FischerDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA.
Warren S WarrenDepartment of Chemistry, Duke University, Durham, North Carolina 27708, USA.
Duke University · USDuke Medical Center · USThe University of Texas Medical Branch at Galveston · US

Funding

INTEGRATED CENTER FOR IN VIVO MICROSCOPYP41EB015897 · NIBIB · DUKE UNIVERSITY · PI JOHNSON, GEORGE ALLAN · 2012 to 2017
$7.4M
Improving Melanoma Diagnosis with Pump-Probe Optical ImagingR01CA166555 · NCI · DUKE UNIVERSITY · PI WARREN, WARREN S · 2013 to 2017
$1.6M
Multi-modality optical molecular imaging for melanoma tumor margin assessmentF32CA183204 · NCI · DUKE UNIVERSITY · PI ROBLES, FRANCISCO E · 2014 to 2016
$131k
Novel Techniques in Nonlinear Optical Microscopy for Improving Melanoma DiagnosisF32CA168497 · NCI · DUKE UNIVERSITY · PI WILSON, JESSE WILLIAM · 2013 to 2015
$129k
NCI NIH HHS F32 CA168497NCI NIH HHS F32 CA183204NCI NIH HHS R01 CA166555NIBIB NIH HHS P41 EB015897
6 · The paper itself

Abstract

Metastatic melanoma is associated with a poor prognosis, but no method reliably predicts which melanomas of a given stage will ultimately metastasize and which will not. While sentinel lymph node biopsy (SLNB) has emerged as the most powerful predictor of metastatic disease, the majority of people dying from metastatic melanoma still have a negative SLNB. Here we analyze pump-probe microscopy images of thin biopsy slides of primary melanomas to assess their metastatic potential. Pump-probe microscopy reveals detailed chemical information of melanin with subcellular spatial resolution. Quantification of the molecular signatures without reference standards is achieved using a geometrical representation of principal component analysis. Melanin structure is analyzed in unison with the chemical information by applying principles of mathematical morphology. Results show that melanin in metastatic primary lesions has lower chemical diversity than non-metastatic primary lesions, and contains two distinct phenotypes that are indicative of aggressive disease. Further, the mathematical morphology analysis reveals melanin in metastatic primary lesions has a distinct "dusty" quality. Finally, a statistical analysis shows that the combination of the chemical information with spatial structures predicts metastatic potential with much better sensitivity than SLNB and high specificity, suggesting pump-probe microscopy can be an important tool to help predict the metastatic potential of melanomas.

Indexed as

(170.3880) Medical and biological imaging(180.5810) Scanning microscopy(320.7150) Ultrafast spectroscopy

Identifiers

PMID26417529
PMCPMC4574685
OpenAlexW2204907259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.